Key Metrics
13
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.005 - 0.01
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
158
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.94
5-Year SI
5-year SI
- N/A 2-year SI
- 0.92 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.94
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
26%
4 to 6 months
53%
7 to 9 months
19%
Above 9 months
2%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Mucin
- Cancer
- Tumor progression
- Platelet
- Cytoskeleton
- Proteasome
- Immunotherapy
- Lung cancer
- CDK inhibitor
- Medulloblastoma
- Systemic therapy
- Chemotherapy
- Cyclooxygenase
- Systematic review
- Smooth muscle
- Pancreatic cancer
- Carcinogenesis
- Bone marrow
- Extracellular matrix
- Tumor microenvironment
Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1982 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Cancer and Metastasis Reviews ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond
- 7 Dec 24
- Cancer and Metastasis Reviews
-
Full paper
Correlative studies reveal factors contributing to successful CAR-T cell therapies in cancer.
- 3 Dec 24
- Cancer metastasis reviews
-
Full paper
CAR T-cell therapy to treat multiple myeloma: current state and future directions.
- 3 Dec 24
- Cancer metastasis reviews
-
Full paper
Ribosomal rodeo: wrangling translational machinery in gynecologic tumors
- 2 Dec 24
- Cancer and Metastasis Reviews
-
Full paper
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms.
- 1 Dec 24
- Cancer metastasis reviews
-
Full paper
The roles of periostin derived from cancer-associated fibroblasts in tumor progression and treatment response.
- 30 Nov 24
- Cancer metastasis reviews
Scite analysis
Powered by scite_
2k articles received 103.4k citations see all
- 2,174 Supporting
- 99,492 Mentioning
- 172 Contrasting
Editorial notices
- 3 Retractions
- 0 Withdrawals
- 15 Corrections
- 20 Errata
- 0 Expression of Concern
FAQs
How long has Cancer and Metastasis Reviews been actively publishing?
Cancer and Metastasis Reviews has been in operation since 1982 till date.
What is the publishing frequency of Cancer and Metastasis Reviews ?
Cancer and Metastasis Reviews published with a Quarterly frequency.
How many articles did Cancer and Metastasis Reviews publish last years ?
In 2023, Cancer and Metastasis Reviews published 85 articles.
What is the eISSN & pISSN for Cancer and Metastasis Reviews ?
For Cancer and Metastasis Reviews,eISSN is 1573-7233 and pISSN is0167-7659.
What is Citescore for Cancer and Metastasis Reviews ?
Citescore for Cancer and Metastasis Reviews is 13.
What is H index for Cancer and Metastasis Reviews ?
H index for Cancer and Metastasis Reviews is 158.
What is SNIP score for Cancer and Metastasis Reviews ?
SNIP score for Cancer and Metastasis Reviews is 1.94.
What is the SJR for Cancer and Metastasis Reviews ?
SJR for Cancer and Metastasis Reviews is Q1.
Who is the publisher of Cancer and Metastasis Reviews ?
SPRINGER is the publisher of Cancer and Metastasis Reviews.